Genotyping Market Research Report-Global Forecast till 2027

Genotyping Market Information by Technology (Sequencing, Capillary Electrophoresis, PCR, and Others), Product (Reagents and Kits and Others), Application (Diagnostics and Others), End-User (Hospitals, Diagnostic Centers), and Region-Global Forecast till 2027

ID: MRFR/LS/5172-HCR | February 2021 | Region: Global | 85 pages

Please note that the assessment period of report has been updated from 2018–2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


The Global Genotyping Market accounted for USD 6120 million in 2015 and expected to register healthy growth during the forecast period (2018–2023) at a CAGR of 22.5%.


Genotyping services help to understand the genetic structure of any living organisms such as humans, animals, plants, and microorganisms. Human genotyping provides data related to the genetic history of an individual; microorganism genotyping provide aid in research and development of bacterial and viral diseases. The increasing research and development activities in the healthcare sector, rising prevalence of genetic diseases, technological advancement, and surge in demand for personalized medication are expected to drive the growth of the market. Moreover, decreasing prices of genotyping services due to intense competition is contributing to the growth of the market. According to the Centers for Disease Control and Prevention (CDC), Genetic disorders are constantly increasing, and in the US more than 120000 babies are born with congenital disabilities, which are caused by genetic changes.


The uncertainty related to reimbursement and lack of skilled people may hamper the growth of the market during the assessment period.


Segmentation


The Global Genotyping Market has been segmented on the basis of technology, product, application, and end-user.


On the basis of technology, the market has been classified as sequencing, capillary electrophoresis, PCR, microarray, and mass spectrometry. The sequencing segment has been further divided into next-generation sequencing, pyrosequencing, and Sanger sequencing. The Capillary electrophoresis segment has been further divided into amplified fragment length polymorphism (AFLP),single-strand conformation polymorphism (SSCP), and restriction fragment length polymorphism (RFLP). The microarray segment has been classified as DNA microarrays, antibody microarrays, MMChips, and peptide microarrays.


The product segment has been divided into reagents and kits, instruments, and services.


The application segment has been classified into diagnostics, drug discovery and development, agriculture, academic research, and personalized medicine.


The market, by end-user, has been segmented into hospitals, diagnostic centers, academic institutes, and research and development centers.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The genotyping market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European genotyping market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The genotyping market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The genotyping market in the Middle East & Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Genotyping Market Share, by Region, 2017 (%)


Global Genotyping Market Share, by Region, 2017 (%)


Source: MRFR Analysis


The Americas are likely to dominate the global genotyping market owing to the well-established healthcare sector, increasing demand for personalized medicines, and a surge in research and development activities in the region. Moreover, increasing cases of genetic disorders is propelling the growth of the market. According to the report published by Alzheimer's Association in 2018, Prevalence of Alzheimer's disease is continuously increasing, and in the US 5.7 million Americans are living with the disease also it costs around USD 277 billion to the nation.


The European market is expected to be the second-largest genotyping market. The market growth in this region can be attributed to the increase in healthcare expenditure, government initiatives for increasing research and development in the region and increasing expenditure on R&D by pharmaceutical companies. According to the European Federation of Pharmaceutical Industries and Associations in 2015, pharmaceutical companies in the European region invested more than USD 38664 million in research and development activities.


Asia-Pacific is expected to be the fastest-growing genotyping market during the forecast period due to the increasing disposable income, favorable government policies, and rising investments in healthcare and expansions by market players in the region. For instance, in April 2018, Agilent Technologies, Inc. has opened a global solution development center in Singapore to provide services related to pharma, biopharma, lipidomic, and food testing.


The market in the Middle East & Africa is expected to account for the smallest share of the global genotyping market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.


Key Players


Some of the key players in the global genotyping market are QIAGEN, Affymetrix, Inc., Illumina, Inc, Thermo Fisher Scientific, Inc., General Electric Company, Agilent Technologies, Inc., Fluidigm Corporation, Sequenom, F. Hoffmann-La Roche Ltd, and Beckman Coulter, Inc.


Global Genotyping Market, by Technology



  • Technology

    • Sequencing

      • Next-Generation Sequencing

      • Pyrosequencing

      • Sanger Sequencing



    • Capillary Electrophoresis

      • Amplified Fragment Length Polymorphism (AFLP)

      • Single-Strand Conformation Polymorphism (SSCP)

      • Restriction Fragment Length Polymorphism (RFLP)



    • PCR

    • Microarray

      • DNA Microarrays

      • Antibody Microarrays

      • Mmchips

      • Peptide Microarrays








    • Mass Spectrometry



Global Genotyping Market, by Product



  • Reagents and Kits

  • Instruments    


    • Sequencer

    • Amplifiers


  • Services


Global Genotyping Market, by Application



  • Diagnostics

  • Drug Discovery and Development

  • Academic Research

  • Research and Development Centers


Global Genotyping Market, by End User



  • Hospitals

  • Diagnostic Centers

  • Academic Institutes

  • Research and Development Centers


Global Genotyping Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • South America





  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • Africa




Intended Audience



  • Biotechnology companies

  • Bioinformatics service providers

  • Medical devices manufacturers

  • Bio supplier companies

  • Genotyping product distributors and suppliers

  • Healthcare providers

  • Research institutes and academic centers



Table of Contents

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Genotyping Market, by Technology

6.1 Introduction

6.2 Sequencing

6.2.1 Next-Generation Sequencing

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.2 Pyrosequencing

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.3 Sanger Sequencing

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Capillary Electrophoresis

6.3.1 Amplified Fragment Length Polymorphism (AFLP)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.2 Single-Strand Conformation Polymorphism (SSCP)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.3 Restriction Fragment Length Polymorphism (RFLP

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 PCR

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5 Microarray

6.5.1 DNA microarrays

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5.2 Antibody microarrays

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5.3 MMChips

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5.4 Peptide microarrays

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6 Mass Spectrometry

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Genotyping Market, by Product

7.1 Introduction

7.2 Reagents And Kits

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Instruments

7.3.1 Sequencer

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3.2 Amplifiers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Services

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Genotyping Market, by Application

8.1 Introduction

8.2 Diagnostics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Drug Discovery And Development

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Agriculture

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.5 Academic Research

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.6 Personalized Medicine

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Genotyping Market, by End-User

9.1 Introduction

9.2 Hospitals

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.3 Diagnostic Centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.4 Academic Institutes

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.5 Research and Development Centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.6 Personalized Medicine

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 10. Global Genotyping Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12. Company Profiles

12.1 QIAGEN

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 Affymetrix, Inc.

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Illumina, Inc

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Thermo Fisher Scientific, Inc.

12.4.1 Company Overview

12.4.2 Technology/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 GENERAL ELECTRIC COMPANY

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Agilent Technologies, Inc.

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Fluidigm Corporation

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Sequenom

12.8.1 Overview

12.8.2 Product/ Technology Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 F. Hoffmann-La Roche Ltd

12.9.1 Overview

12.9.2 Product Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Beckman Coulter, Inc.

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s Viewpoint

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Predictions for the Genotyping Industry

Chapter 14. Appendix

LIST OF TABLES

Table 1 Global Genotyping Market Synopsis, 2020-2027

Table 2 Global Genotyping Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Genotyping Market, by Region, 2020-2027 (USD Million)

Table 4 Global Genotyping Market, by Technology 2020-2027 (USD Million)

Table 5 Global Genotyping Market, by Product, 2020-2027 (USD Million)

Table 6 Global Genotyping Market, by End-User, 2020-2027 (USD Million)

Table 7 Global Genotyping Market, by Application, 2020-2027 (USD Million)

Table 8 North America: Genotyping Market, by Technology, 2020-2027 (USD

Million)

Table 9 North America: Genotyping Market, by Product, 2020-2027 (USD

Million)

Table 10 North America: Genotyping Market, by Application, 2020-2027 (USD

Million)

Table 11 North America: Genotyping Market, by End-User, 2020-2027 (USD

Million)

Table 12 US: Genotyping Market, by Technology, 2020-2027 (USD Million)

Table 13 US: Genotyping Market, by Product, 2020-2027 (USD Million)

Table 14 US: Genotyping Market, by Application, 2020-2027 (USD Million)

Table 15 US: Genotyping Market, by End-User, 2020-2027 (USD Million)

Table 16 Canada: Genotyping Market, by Technology, 2020-2027 (USD Million)

Table 17 Canada: Genotyping Market, by Product, 2020-2027 (USD Million)

Table 18 Canada: Genotyping Market, by Application, 2020-2027 (USD

Million)

Table 19 Canada: Genotyping Market, by End-User, 2020-2027 (USD

Million)

Table 20 South America: Genotyping Market, by Technology, 2020-2027 (USD

Million)

Table 21 South America: Genotyping Market, by Product, 2020-2027 (USD

Million)

Table 22 South America: Genotyping Market, by Application, 2020-2027 (USD

Million)

Table 23 South America: Genotyping Market, by End-User, 2020-2027 (USD

Million)

Table 24 Europe: Genotyping Market, by Technology, 2020-2027 (USD Million)

Table 25 Europe: Genotyping Market, by Product, 2020-2027 (USD Million)

Table 26 Europe: Genotyping Market, by Application, 2020-2027 (USD Million)

Table 27 Europe: Genotyping Market, by End-User, 2020-2027 (USD Million)

Table 28 Western Europe: Genotyping Market, by Technology, 2020-2027 (USD

Million)

Table 29 Western Europe: Genotyping Market, by Product, 2020-2027 (USD

Million)

Table 30 Western Europe: Genotyping Market, by Application, 2020-2027

(USD Million)

Table 31 Western Europe: Genotyping Market, by End-User, 2020-2027

(USD Million)

Table 32 Eastern Europe: Genotyping Market, by Technology, 2020-2027 (USD

Million)

Table 33 Eastern Europe: Genotyping Market, by Product, 2020-2027 (USD

Million)

Table 34 Eastern Europe: Genotyping Market, by Application, 2020-2027

(USD Million)

Table 35 Eastern Europe: Genotyping Market, by End-User, 2020-2027

(USD Million)

Table 36 Asia-Pacific: Genotyping Market, by Technology, 2020-2027 (USD

Million)

Table 37 Asia-Pacific: Genotyping Market, by Product, 2020-2027 (USD

Million)

Table 38 Asia-Pacific: Genotyping Market, by Application, 2020-2027 (USD

Million)

Table 39 Asia-Pacific: Genotyping Market, by End-User, 2020-2027 (USD

Million)

Table 40 Middle East & Africa: Genotyping Market, by Technology, 2020-2027

(USD Million)

Table 41 Middle East & Africa: Genotyping Market, by Product, 2020-2027

(USD Million)

Table 42 Middle East & Africa: Genotyping Market, by Application, 2020-2027

(USD Million)

Table 43 Middle East & Africa: Genotyping Market, by End-User, 2020-2027

(USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Genotyping Market

Figure 3 Segmentation Market Dynamics for Global Genotyping Market

Figure 4 Global Genotyping Market Share, by Technology , 2020

Figure 5 Global Genotyping Market Share, by Product, 2020

Figure 6 Global Genotyping Market Share, by Application, 2020

Figure 7 Global Genotyping Market Share, by End-User, 2020

Figure 8 Global Genotyping Market Share, by Region, 2020

Figure 9 North America: Genotyping Market Share, by Country, 2020

Figure 10 Europe: Genotyping Market Share, by Country, 2020

Figure 11 Asia-Pacific: Genotyping Market Share, by Country, 2020

Figure 12 Middle East & Africa: Genotyping Market Share, by Country, 2020

Figure 13 Global Genotyping Market: Company Share Analysis, 2020 (%)

Figure 14 QIAGEN : Key Financials

Figure 15 QIAGEN : Segmental Revenue

Figure 16 QIAGEN : Geographical Revenue

Figure 17 Affymetrix, Inc.: Key Financials

Figure 18 Affymetrix, Inc.: Segmental Revenue

Figure 19 Affymetrix, Inc.: Geographical Revenue

Figure 20 Illumina, Inc: Key Financials

Figure 21 Illumina, Inc: Segmental Revenue

Figure 22 Illumina, Inc: Geographical Revenue

Figure 23 Thermo Fisher Scientific, Inc.: Key Financials

Figure 23 Thermo Fisher Scientific, Inc.: Segmental Revenue

Figure 25 Thermo Fisher Scientific, Inc.: Geographical Revenue

Figure 26 GENERAL ELECTRIC COMPANY: Key Financials

Figure 27 GENERAL ELECTRIC COMPANY: Segmental Revenue

Figure 28 GENERAL ELECTRIC COMPANY. Geographical Revenue

Figure 29 Agilent Technologies, Inc.: Key Financials

Figure 30 Agilent Technologies, Inc.: Segmental Revenue

Figure 31 Agilent Technologies, Inc.: Geographical Revenue

Figure 32 Fluidigm Corporation : Key Financials

Figure 33 Fluidigm Corporation : Segmental Revenue

Figure 34 Fluidigm Corporation : Geographical Revenue

Figure 35 Sequenom: Key Financials

Figure 36 Sequenom: Segmental Revenue

Figure 37 Sequenom: Geographical Revenue

Figure 38 F. Hoffmann-La Roche Ltd: Key Financials

Figure 39 F. Hoffmann-La Roche Ltd: Segmental Revenue

Figure 40 F. Hoffmann-La Roche Ltd: Geographical Revenue

Figure 41 Beckman Coulter, Inc.: Key Financials

Figure 42 Beckman Coulter, Inc.: Segmental Revenue

Figure 43 Beckman Coulter, Inc.: Geographical Revenue